30.12.2021 - WALTHAM, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the 40th Annual J.P. Morgan Healthcare .
Repligen Corporation to Present at 40th Annual J.P. Morgan Healthcare Conference - read this article along with other careers information, tips and advice on BioSpace